Psychiatric neuroimaging: Joining forces with epidemiology

European Psychiatry

Volumn 23, Issue 4, 2008, Pages 315-319

  Glahn, David ^a   Reichenberg, Abraham ^b   Frangou, Sophia ^b   Ormel, Hans ^c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Bipolar disorder; Psychosis; Risk factors; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; CANNABIS; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN;

ARTICLE; BRAIN MAPPING; DISEASE PREDISPOSITION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; MEDICAL RESEARCH; MENTAL DISEASE; MOOD DISORDER; NEUROIMAGING; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCHIZOPHRENIA; TREATMENT RESPONSE;

BIPOLAR DISORDER; BRAIN; CASE-CONTROL STUDIES; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; EPISTASIS, GENETIC; HUMANS; MASS SCREENING; PHENOTYPE; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SOCIAL ENVIRONMENT;

EID: 46649101805     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2007.09.014     Document Type: Article

References (34)

1. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., and Moffitt T.E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325 (2002) 1212-1213
2. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61 (2004) 774-780
3. Cannon M., Jones P.B., and Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 159 (2002) 1080-1092
4. Cannon T.D. Clinical and genetic high-risk strategies in understanding vulnerability to psychosis. Schizophr Res 79 (2005) 35-44
5. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57 (2005) 1117-1127
6. Chang L., Yakupov R., Cloak C., and Ernst T. Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain 129 Pt 5 (2006) 1096-1112
7. Darwin C.R. The effects of cross and self-fertilisation in the vegetable kingdom (1876), John Murray, London
8. Davidson M., Reichenberg A., Rabinowitz J., Weiser M., Kaplan Z., and Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 156 (1999) 1328-1335
9. Earls F. Epidemiology and child psychiatry: entering the second phase. Am J Orthopsychiatry 59 (1989) 279-283
10. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry 66 Suppl. 10 (2005) 3-8
11. Fu C.H., Williams S.C., Cleare A.J., Brammer M.J., Walsh N.D., Kim J., et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61 (2004) 877-889
12. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 297 (2002) 400-403
13. Hariri A.R., and Weinberger D.R. Functional neuroimaging of genetic variation in serotonergic neurotransmission. Genes Brain Behav 2 (2003) 341-349
14. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10 (2005) 40-68
15. Honey G.D., Bullmore E.T., Soni W., Varatheesan M., Williams S.C., and Sharma T. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci U S A 96 (1999) 13432-13437
16. Jager G., Kahn R.S., Van Den Brink W., Van Ree J.M., and Ramsey N.F. Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology (Berl) 185 (2006) 358-368
17. Jager G., Van Hell H.H., De Win M.M., Kahn R.S., Van Den Brink W., Van Ree J.M., et al. Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur Neuropsychopharmacol 17 (2007) 289-297
18. Jones P., Rodgers B., Murray R., and Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344 (1994) 1398-1402
19. Kendler K.S., Davis C.G., and Kessler R.C. The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study. Br J Psychiatry 170 (1997) 541-548
20. Kendler K.S., Neale M.C., and Walsh D. Evaluating the spectrum concept of schizophrenia in the Roscommon Family Study. Am J Psychiatry 152 (1995) 749-754
21. Kessler R.C., and Walters E.E. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 7 1 (1998) 3-14
22. King M., Coker E., Leavey G., Hoare A., and Johnson-Sabine E. Incidence of psychotic illness in London: comparison of ethnic groups. BMJ 309 (1994) 1115-1119
23. Liddle P.F., Friston K.J., Frith C.D., Hirsch S.R., Jones T., and Frackowiak R.S. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 160 (1992) 179-186
24. Lopez A.D., and Murray C.C. The global burden of disease, 1990-2020. Nat Med 4 (1998) 1241-1243
25. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8 (1997) 1057-1061
26. McGuire P.K., Shah G.M.S., and Murray R.M. Increased blood flow in Broca's area during auditory hallucinations in schizophrenia. Lancet 342 (1993) 703-706
27. van Os J., Pedersen C.B., and Mortensen P.B. Confirmation of synergy between urbanicity and familial liability in the causation of psychosis. Am J Psychiatry 161 (2004) 2312-2314
28. Reichenberg A., Weiser M., Rabinowitz J., Caspi A., Schmeidler J., Mark M., et al. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry 159 (2002) 2027-2035
29. Reiss A.L., and Dant C.C. The behavioral neurogenetics of fragile X syndrome: analyzing gene-brain-behavior relationships in child developmental psychopathologies. Dev Psychopathol 15 (2003) 927-968
30. Shergill S.S., Brammer M.J., Williams S.C., Murray R.M., and McGuire P.K. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry 57 (2000) 1033-1038
31. Slattery D.A., Hudson A.L., and Nutt D.J. Invited review: the evolution of antidepressant mechanisms. Fundam Clin Pharmacol 18 (2004) 1-21
32. Szatmari P., White J., and Merikangas K.R. The use of genetic epidemiology to guide classification in child and adult psychopathology. Int Rev Psychiatry 19 (2007) 483-496
33. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44 (1987) 660-669
34. Zammit S., Allebeck P., David A.S., Dalman C., Hemmingsson T., Lundberg I., et al. A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry 61 (2004) 354-360